For expanding the production of finished pharmaceutical products and APIs, Farmak has launched GMP-compliant substances manufacturing line in Shostka. It is a modern complex with manufacturing sites, quality control laboratory, and logistics center.
In mid-December, Farmak applied for an extended license for a new manufacturing line. During 21-22 December 2015, the State Administration of Ukraine on Medicinal Products conducted the certification of the Quality Control Laboratory and verification of compliance with licensing conditions.
Based on the audit results, Farmak obtained permission for further APIs production on the new facilities in Shostka.
When buying Corvalol, consumers mean a drug under the brand of Farmak, which has been produced at the plant since 1959. This conclusion was made by International Marketing Group during its study of the level of consumer awareness of the drug marked “CORVALOL”. Most of the respondents surveyed noted that the drug called “Corvalol” is […]
As part of the celebration of the 60th anniversary of the first release of Corvalol manufactured by Farmak, leader of the Ukrainian pharmaceutical market, the Ukrainian Book of Records has recognized Corvalol by Farmak as the most known sedative in Ukraine. Corvalol by Farmak is a globally known medicinal product that has already become a […]
On Sunday, February 24, the final matches within UFAM League 3rd season (Kyiv Open Futsal Championship among health care institutions) took place. The tournament which started at the end of 2018 was ended with the great sport and health event. 12 teams participated in the competition this year, including the players from the Cardiology Institute, Kyiv [&hell...